Athos Therapeutics Inc.

Athos Therapeutics Inc. is a clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel Disease and other inflammatory diseases. The company leverages a unique platform that integrates medicinal chemistry and systems biology through machine learning to identify and develop novel drugs for patients with autoimmune and chronic inflammatory diseases, with a mission to improve human health through science and AI.